Co‐Designing Lung Cancer Rehabilitation Services for People Treated With Immunotherapy
Health Expectations · 2026-04 · 29 (2)
DOI: 10.1111/hex.70660 ↗At a glance
Journal article in Health Expectations, published online on 2026-04-05. Written by Lara Edbrooke and 3 co-authors. Institution: Department of Physiotherapy, The University of Melbourne, Melbourne, Australia. Major MEDLINE topics: Lung Neoplasms, Immunotherapy. 47 references. The full text is freely available (open access, CC BY 4.0). Funded by: Victorian Cancer Agency.
Abstract (original language)
Background
Immunotherapy has rapidly become part of lung cancer care, however the ability of people to participate in rehabilitation in conjunction with immunotherapy remains largely unknown. The aims of this study were to (a) understand stakeholder perspectives of lung cancer immunotherapy treatment and (b) co‐design a rehabilitation programme for people with lung cancer during and following immunotherapy.
Methods
Experience‐based co‐design, involving three distinct online phases: (1) patient, carer and healthcare professional interviews to understand immunotherapy and rehabilitation experiences; (2) separate workshops for healthcare professionals and patients/carers, to identify priority areas for future rehabilitation programme design; and (3) combined workshops to refine the draft programme. Transcripts were analysed by two researchers, guided by the Consolidated Framework for Implementation Research.
Results
Seventeen stakeholders were involved in the interviews and/or workshops: seven patients, one carer and nine exercise healthcare professionals. Key themes included: immunotherapy side effects varied but were generally more tolerable than chemotherapy; rehabilitation information was lacking, and access varied; healthcare professional training in immunotherapy was limited. Rehabilitation enablers included supervision and monitoring from healthcare professionals with expertise in cancer; routine rehabilitation discussion with oncologists and nurses; dedicated funding. Lack of education about symptom control when exercising was a barrier for patients. Essential rehabilitation elements included individualised programmes, group‐based, flexibility for centre‐ or home‐based programmes. Programme components included education, aerobic and strength exercise and screening for nutrition and psychology needs.
Conclusions
This research has furthered understanding of the lung cancer immunotherapy treatment journey and identified key design requirements of a rehabilitation programme. Patient or Public Contribution Two patient advocates contributed to this study as members of the project steering committee. Their contributions for this study included reviewing and providing feedback on the proposed study design and the interview and workshop topic and question guides. Patient, carer and healthcare professionals co‐designed the rehabilitation programme through individual interviews and a series of small‐group workshops.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Physiotherapy, The University of Melbourne, Melbourne, Australia.
- Centre for Health Services Research in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
ORCID profiles: Lara Edbrooke, Catherine L Granger
Funding
- Victorian Cancer Agency
Cite
APA
Edbrooke, L., Pearson, E., Granger, C. L., & Denehy, L. (2026). Co‐Designing Lung Cancer Rehabilitation Services for People Treated With Immunotherapy. Health Expectations, 29(2). https://doi.org/10.1111/hex.70660
Vancouver
Edbrooke L, Pearson E, Granger CL, Denehy L. Co‐Designing Lung Cancer Rehabilitation Services for People Treated With Immunotherapy. Health Expectations. 2026;29(2). doi:10.1111/hex.70660
BibTeX
@article{Edbrooke2026,
author = {Edbrooke, Lara and Pearson, Elizabeth and Granger, Catherine L and Denehy, Linda},
title = {Co‐Designing Lung Cancer Rehabilitation Services for People Treated With Immunotherapy},
journal = {Health Expectations},
year = {2026},
volume = {29},
number = {2},
doi = {10.1111/hex.70660}
}
EUVIMED